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Transcription factorthe most common type of birth defect with an incidence of 1%. Previously, we
described a point mutation in GATA4 that segregated with cardiac defects in a family with autosomal
dominant disease. The mutation (G296S) exhibited biochemical deﬁcits and disrupted a novel interaction
between Gata4 and Tbx5. To determine if Gata4 and Tbx5 genetically interact in vivo, we generated mice
heterozygous for both alleles. We found that nearly 100% of mice heterozygous for Gata4 and Tbx5 were
embryonic or neonatal lethal and had complete atrioventricular (AV) septal defects with a single AV valve
and myocardial thinning. Consistent with this phenotype, Gata4 and Tbx5 are co-expressed in the developing
endocardial cushions and myocardium. In mutant embryos, cardiomyocyte proliferation deﬁcits were
identiﬁed compatible with the myocardial hypoplasia. Similar to Gata4, Gata6 and Tbx5 are co-expressed in
the embryonic heart, and the transcription factors synergistically activate the atrial natiuretic factor
promoter. We demonstrate a genetic interaction between Gata6 and Tbx5 with an incompletely penetrant
phenotype of neonatal lethality and thin myocardium. Gene expression analyses were performed on both
sets of compound heterozygotes and demonstrated downregulation of α-myosin heavy chain only in Gata4/
Tbx5 heterozygotes. These ﬁndings highlight the unique genetic interactions of Gata4 and Gata6 with Tbx5
for normal cardiac morphogenesis in vivo.
© 2008 Elsevier Inc. All rights reserved.IntroductionCongenital heart disease (CHD) is the most common type of birth
defect affecting nearly 1% of all live births and defects of cardiac
septation are the most frequent form of CHD (Hoffman and Kaplan,
2002). The majority of CHD has a multifactorial etiology but recent
studies have identiﬁed monogenic etiologies for a subset of CHD
(Garg, 2006; Ransom and Srivastava, 2007; Bruneau, 2008). The
causative genes often result in disease in the setting of haploinsufﬁ-
ciency suggesting that gene dosage is critical for normal cardiac
morphogenesis. CHD-causing genes have beenwell studied in murine
heart development. Targeted deletion of these genes nearly always
results in embryonic lethality and severe cardiac malformations while
heterozygous mice are often unaffected. As is often the case, humand Molecular Biology University
ines Boulevard, Rm. NA8.124,
arg).
lar Disease and Department of
Owens Street, San Francisco,
l rights reserved.cardiac disease-causing genes encode for proteins that are part of
transcriptional complexes (Jimenez-Sanchez et al., 2001).
We previously discovered that mutations in GATA4 were associated
with CHD, most commonly cardiac septal defects (CSD) and pulmonary
valve stenosis (Garg et al., 2003). Subsequently, other investigators
reported additionalGATA4mutations in individualswith CHD (Nemer et
al., 2006; Rajagopal et al., 2007; Tomita-Mitchell et al., 2007). Gata4
belongs to a family of zinc ﬁnger transcription factors that includes six
known family members, Gata 1–6, and Gata4 and Gata6 are important
for cardiovascular development (Molkentin, 2000). Gata4 is expressed
in multiple cell types that are critical for proper cardiac septation and
these include endocardial, myocardial and cushion mesenchymal cells
(Pu et al., 2004). Initial studies demonstrated that targeted deletion of
Gata4 in mice results in early embryonic lethality and cardiac biﬁda
likely secondary to an endodermal defect (Kuo et al., 1997;Molkentin et
al., 1997). The dosage sensitivity and functions of Gata4 during later
stages of cardiac morphogenesis have been demonstrated in numerous
studies that have shown cardiac malformations in mice harboring a
hypomorphic Gata4 allele and tissue-speciﬁc deletions of Gata4
(Crispino et al., 2001; Pu et al., 2004; Watt et al., 2004; Zeisberg et al.,
2005; Rivera-Feliciano et al., 2006). Although Gata6 is expressed in the
developing heart, targeted disruption of Gata6 in the mouse results in
369M. Maitra et al. / Developmental Biology 326 (2009) 368–377early embryonic lethality prior to cardiac development. Recent mouse
studies have demonstrated an in vivo functional role for Gata6 in heart
development aswell (Koutsourakis et al.,1999;Morrisey et al.,1998; Xin
et al., 2006; Lepore et al., 2006).
Tbx5 is a T-box containing transcription factor that is critical for
proper limb and heart development. TBX5 mutations that result in
haploinsufﬁciency cause Holt–Oram syndrome, which is characterized
by congenital heart defects, conduction-system abnormalities and
upper-limbdeformities (Basson et al.,1997; Li et al.,1997). The structural
cardiac manifestations of Holt–Oram syndrome range from atrial and
ventricular septal defects tomore severe defects such as hypoplastic left
heart syndrome (Basson et al., 1994; Newbury-Ecob et al., 1996). The
developmental expression pattern of the Tbx5 protein localizes to
tissues affected by Holt–Oram syndrome (Bruneau et al., 1999; Hatcher
et al., 2000). Tbx5 homozygous knockoutmice are embryonic lethal due
to arrestedcardiacmorphogenesis indicating avital role for Tbx5 inearly
heart development. Mice heterozygous for Tbx5 develop heart and limb
abnormalities and also express a unique gene expression pattern
demonstrating the dosage sensitivity for this transcription factor during
heart development (Bruneau et al., 2001; Mori et al., 2006).
Cardiac morphogenesis is a complex process that is regulated by
numerous highly conserved transcription factors, which interact in a
precise and coordinated manner (Olson 2006; Srivastava, 2006). We
previously demonstrated that Gata4 and Tbx5 physically interact in
co-immunoprecipitation assays and cooperatively activate a common
luciferase reporter, atrial natiuretic factor (ANF), in transactivation
assays (Garg et al., 2003). This novel interaction between Tbx5 and
Gata4 was abolished by mutations in GATA4 or TBX5 that were
identiﬁed in humans with CHD. These ﬁndings suggested that
interaction between the Gata family of transcription factors and
Tbx5 is necessary for proper cardiac morphogenesis.
Here, we show that Gata4, Gata6 and Tbx5 are co-expressed during
cardiac morphogenesis and mice compound heterozygous for either
Gata4 and Tbx5 or Gata6 and Tbx5 suffer embryonic or early neonatal
lethality. The Gata4/Tbx5 compound heterozygotes had cardiovascular
defects that included complete atrioventricular (AV) septal defects and
thin myocardium. The cardiac phenotype of the Gata6/Tbx5 compound
heterozygoteswas less severe and involved only variable thinning of the
myocardium. Cardiac gene expression analysis of Gata4+/−Tbx5+/−
heterozygotes revealed decreased mRNA levels of α-myosin heavy
chain (or Myh6), a direct target of Gata4 and Tbx5 that has been
implicated as a cause of human atrial septal defects (Molkentin et al.,
1994; Huang et al., 1995; Ching et al., 2005). These ﬁndings provide
insight into the genetic pathways cooperatively regulated by Gata4,
Gata6 and Tbx5 that when altered lead to cardiac malformations.
Materials and methods
Breeding and collection of mouse embryos
Mice were maintained on a 0600 to 1800 h light–dark cycle, with
noon of the dayof observation of a vaginal plug deﬁned as embryonic day
(E) 0.5.Mice heterozygous forGata4,Gata6, and Tbx5were generated and
genotyped as previously described (Molkentin et al., 1997; Bruneau et al.,
2001;Xinet al., 2006). These lineshavebeenmaintained inmixedgenetic
backgrounds: Gata4/Gata6 are in 129/C57BL6 while Tbx5 are in Black
Swiss/129. To generate the double heterozygote mice used in this study,
mice heterozygous for Gata4 or Gata6 were mated to Tbx5 heterozygote
mice and pregnant mothers or newborn litters were sacriﬁced at various
embryonic and postnatal timepoints. Wildtype littermates were used as
controls for histologic sections and gene expression studies.
Histologic and radioactive section in situ hybridization
To fully characterize the phenotype of the single and double
heterozygote mice, histological analysis was performed. Pregnantmothers were sacriﬁced to obtain embryos, which were ﬁxed in 4%
paraformaldehyde for sectioning. Hematoxylin and eosin (H and E)
staining was carried out on heart sections using standard methods to
identify any defects. Histological 3-D reconstruction was performed
using episcopic ﬂuorescence image capture on E14.5 murine embryos
to examine the cardiac phenotype (Rosenthal et al., 2004). Myocardial
wall thickness was quantiﬁed by measuring the thickness of the
compact myocardium in the right and left ventricles at the level of the
tricuspid and mitral valve in coronal sections of embryonic hearts. A
minimum of four measurements was obtained for each embryo and
means and standard deviations were calculated. In situ hybridization
was performed as described previously (Garg et al., 2001) using 35S-
labeled antisense probes synthesized with T3, T7, or SP6 RNA
polymerase (Maxiscript; Ambion Inc., Austin, TX) from mouse Myh6,
Bmp2, Bmp4, and Notch1 cDNA.
Proliferation and apoptosis assays
Embryos were collected as described above. For these immunostain-
ing studies, histologic sections were deparaﬁnnized in xylene and
rehydrated to phosphate buffered saline (PBS). Proliferation assayswere
performed using the phosphohistone H3 (PH3) antibody (Upstate Cell
Signaling Solutions, Temecula, CA). The sections were permeabilized in
0.3% Triton X-100 in PBS. Sections were then blocked by 3.5% donkey
serum in PBS followed by incubation with 1% rabbit anti-phosphohis-
tone H3 antibody overnight at 4°C. Sections were then washed in PBS
and Cy3 (1%) secondary antibodies (Vector Laboratories, Burlingame,
CA) for 30 min. For cell proliferation studies, contiguous sections were
stained for mouse heavy chain cardiac myosin using Cy3-conjugated
antibody (Abcam, Cambridge, MA) to label the cardiomyocytes. The
percentage of PH3-stained ventricular cardiomyocytes/total number of
ventricular cardiomyocytes was calculated by analyzing a minimum of
three embryos for each genotype. A minimum of four sections per
embryo was analyzed, and the means and standard deviations are
shown. Apoptosis (TUNEL) assays were performed using the In Situ Cell
Death Detection Kit, Fluorescein (Roche) according to manufacturer
instructions. Labeled ventricular cardiomyocytes were counted on a
minimum of six sections of control and mutant embryonic hearts.
Statistical analysis was performed using Student's t-test.
Gene expression analysis
RNAwaspuriﬁed fromembryonicheartsofGata4+/−Tbx5+/− compound
heterozygotes (E11.5 andE13.5); Gata 4+/− (E11.5 andE13.5), Tbx5+/− (E11.5
and E13.5), Gata6+/− (E13.5) single heterozygotes; and Gata6+/− Tbx5+/−
(E13.5) double heterozygotes; and their respective wildtype littermates
using Trizol (Invitrogen). Real-time quantitative reverse transcription-
polymerase chain reaction (qRT-PCR) was performed using the Taqman
Universal PCRMaster Mix kit (Applied Biosystems, Foster City, CA). 25 ng
of total RNAwas used for reverse transcription and ampliﬁcation in each
real-time PCR reaction using a Biorad iQ5 real-time PCR machine.
Commercially available Taqman probes were utilized for the following
genes: Gata4, Gata6, Nkx2.5, Hey1, Hey2, Myh7, Myh6, Bmp2, Bmp4,
Tgfβ1, Tgfβ2, Nfatc1, andNotch1. For Tbx5, a previously published custom
probe designed to amplify exon 3 was used (Mori et al., 2006). Mean
relative gene expressionwas calculated fromwild type andmutant hearts
after normalization to 18s ribosomal RNA, minimum of n=3 per group.
Statistical analysis was performed using Student's t-test, and a p value of
less than 0.05 was considered signiﬁcant.
Luciferase assays
HeLa cells were transfected using Fugene 6 (Roche) according to
manufacturer's instructions. The atrial natriuretic factor luciferase
reporter plasmid (300 ng) and CMV β-galactosidase expression
plasmid (50 ng) to control for transfection efﬁciency were transfected
Fig.1.Gata4, Gata6, and Tbx5 are co-expressed in embryonic heart. Coronal sections of E11.5mouse hearts demonstrate that Gata4mRNA (B), Gata6mRNA (C) and Tbx5mRNA (D) are
co-localized to the atrial and ventricular myocardium by radioactive section in situ hybridization. All genes are co-expressed in the developing atrial septum (arrowhead) and
endocardial cushion derivatives (arrow). Corresponding bright-ﬁeld image is shown in (A). Scale bar represents 100 microns. rv, right ventricle; lv, left ventricle.
370 M. Maitra et al. / Developmental Biology 326 (2009) 368–377along with Gata6 and Tbx5 expression plasmids. Luciferase activity
was measured 48 h after transient transfection as previously
described (Schluterman et al., 2007) and normalized to LacZ
expression to generate relative luciferase activity. Three independent
experiments were performed in duplicate. Statistical comparisons
were performed using Student's t-test.
Results
Co-expression of Gata4 and Tbx5 in the developing heart
Gata4 and Tbx5 are known to be expressed in various cell lineages
and at different stages of cardiac morphogenesis (Molkentin et al.,
1997; Bruneau et al., 1999; Pu et al., 2004). To determine the cardiacFig. 2. Embryonic lethality and intrauterine growth retardation in Embryonic lethality and in
obtained from intercrossing Gata4+/− mice with Tbx5+/− mice is shown and demonstrates e
embryos are growth retarded at E15.5 when compared to wildtype and single heterozygote l
littermates. ⁎, p valueb0.05; scale bar represents 1 mm.cell lineages in which Gata4 and Tbx5 might genetically interact, we
performed in situ hybridization in wildtype E11.5 mouse embryos. As
previously reported, transcripts from both genes were present in the
atrial and ventricular myocardium along with the developing
endocardial cushion mesenchyme (Fig. 1). Gata4 was predominantly
expressed in the developing atrial septum and endocardial cushions
while Tbx5 showed similar increased levels of expression in the atrial
septum along with left ventricular myocardium and pericardium. A
low level of expression of Tbx5 mRNA was present in the right
ventricular myocardium consistent with previous ﬁndings (Bruneau
et al., 1999) (Fig. 1D). The distinct but overlapping expression patterns
of Gata4 and Tbx5 are consistent with these cardiac transcription
factors having cooperative functions in vivo in later stages of cardiac
morphogenesis.trauterine growth retardation in Gata4+/− Tbx5+/− embryos. (A) Frequency of genotypes
mbryonic lethality of Gata4+/− Tbx5+/− mice during late gestation. (B) Gata4+/− Tbx5+/−
ittermates while at E13.5 the mutant embryos (C) are of normal size when compared to
371M. Maitra et al. / Developmental Biology 326 (2009) 368–377Embryonic lethality of Gata4+/− Tbx5 +/− mice
To investigate the functional signiﬁcance of the in vivo interaction
between Gata4 and Tbx5 during cardiac development, we generated
mice heterozygous for both Gata4 and Tbx5 mutant alleles. According
to Mendelian ratios, we expected equal numbers of wildtype, Gata4
heterozygote, Tbx5 heterozygote, and Gata4/Tbx5 double heterozygote
pups to be present in utero and at birth, but only 60% of Tbx5
heterozygotes or Gata4/Tbx5 double heterozygotes to be present at
weaning (postnatal day 28) due to the reported perinatal lethality seen
in Tbx5 heterozygotemice (Bruneau et al., 2001). Genotypic analysis of
36 embryonic and 14 post-natal litters demonstrated that mice
heterozygous for both Gata4 and Tbx5 exhibited nearly 100% lethality
by postnatal day 7 (Fig. 2A). Although, normal Mendelian ratios were
present at E15.5, nearly 50% of these embryos were growth retarded
(Figs. 2A and B). Analysis of E11.5 and E13.5 embryos showed expected
Mendelian ratios with no evidence of growth retardation (Figs. 2A and
C; data not shown). Embryonic lethality of Gata4/Tbx5 double
heterozygotes was observed in the C57BL6/129/Black Swiss mixed
genetic background. Our analysis established that Gata4+/− Tbx5+/−
embryos suffer lethality during the later stages of gestation.
Gata4+/− Tbx5 +/− embryos display atrioventricular septation defects
In order to determine the cause of this early lethality, histological
analysis was performed on E15.5 Gata4+/− Tbx5+/− embryonic hearts
and demonstrated a defect of atrioventricular septation with a single
common atrioventricular valve and associated atrial and ventricularFig. 3. Cardiac defects in Gata4+/− Tbx5+/− embryos. Coronal sections through E15.5 embryon
thin myocardium (arrow) is demonstrated (D). Normal cardiac septation and myocardium ar
found in hearts of Tbx5+/− heterozygotes (C). Scale bar represents 100 μm; ra, right atrium; la
representing the frequency of cardiac abnormalities identiﬁed in each genotype at E14.5 an
septal defect. (F) Decreased ventricular wall thickness in Gata4+/− Tbx5+/− double heterozy
heterozygote littermates. Mean thickness of compact myocardial layer of ventricular wall isseptal defects in all embryos examined (n=7) (Fig. 3). This phenotype
was also demonstrated by histologic 3-D reconstruction of the heart of
an E14.5 embryo (see Supplementary movie). At E15.5, wildtype,
Gata4 heterozygote or Tbx5 heterozygote littermates did not demon-
strate atrioventricular septal defects and had two separate atrioven-
tricular valves with a normal myocardium (Figs. 3A–C). Isolated atrial
septal defects were seen in a portion of Tbx5 heterozygotes, as has
been reported, however none were similar to the Gata4+/−Tbx5+/−
intracardiac defects (Figs. 3C–E). The embryologic basis of complete
atrioventricular septal defects is thought to be abnormal development
of the endocardial cushions. Consistent with this, the atrioventricular
septum, which is derived from endocardial cushion cells, was almost
non-existent in the crux of the Gata4+/− Tbx5+/− E15.5 hearts (Fig. 3D,
asterisk). The process of atrioventricular septation begins at E9.5, and
examination of Gata4+/− Tbx5+/− embryos at E10.5 demonstrated
normal cellularized endocardial cushions when compared to wild-
type, Gata4 heterozygote and Tbx5 heterozygote littermates (Fig. 4A
and data not shown). The endocardial cushions of themutant embryos
had normal expression of Bmp2, Bmp4, and Notch1 by radioactive in
situ hybridization (Fig. 4B and data not shown). The endocardial
cushions are remodeled into separate tricuspid and mitral valves by
E13.5, and the atrioventricular septation defect is present at this
timepoint in the compound heterozygotes. In a similar fashion, gene
expression studies using real time qRT-PCR of E11.5 mutant hearts
demonstrated no signiﬁcant alteration in RNA levels of genes
implicated in endocardial cushion formation except for a mild
decrease in Tgfβ1 to 80% of wildtype levels (Fig. 4C). Additional qRT-
PCR experiments performed using isolated atrioventricular cushionsic hearts (A–D). In Gata4+/− Tbx5+/− embryo, an atrioventricular septation defect (⁎) and
e seen in wildtype (A) and Gata4+/− (B) littermates. An atrial septal defect (arrowhead) is
, left atrium; ivs, interventricular septum; rv, right ventricle; lv, left ventricle. (E) Table
d E15.5. ASD, atrial septal defect; VSD, ventricular septal defect; AVSD, atrioventricular
gotes at E15.5 compared to wildtype, Gata4+/− single heterozygote and Tbx5+/− single
shown in microns. ⁎, p valueb0.05; #, p valueb0.06.
Fig. 4. Endocardial cushion development in Gata4+/− Tbx5+/− embryos. (A) Coronal sections through wildtype and Gata4+/− Tbx5+/− E10.5 embryos demonstrate normal endocardial
cushion formation (arrowhead). (B) Radioactive section in situ hybridization shows normal expression of Bmp2 mRNA in the mesenchyme of the endocardial cushions (arrowheads)
at E10.5. (C) No statistically signiﬁcant alterations in the expression of Bmp2, Bmp4, Tgfβ2, Nfatc1, Notch1, Hey1 and Hey2 in Gata4+/− Tbx5+/− E11.5 embryonic hearts are seen by real
time qRT-PCR. Tgfβ1 is present at ∼80% of wildtype levels. Scale bar represents 100 μm. rv, right ventricle; lv, left ventricle. ⁎, p valueb0.05.
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regulation of Tgfβ1 (data not shown). These ﬁndings suggested
epithelial to mesenchymal transformation (EMT) was normal in
these mutant hearts and that the defect was due to improper
endocardial cushion maturation and remodeling.Gata4+/− Tbx5 +/− embryos have abnormal myocardium
The presence of a complete atrioventricular septal defect should not
lead to prenatal lethality and thereforewe examined theGata4+/− Tbx5+/−
embryos to determine the possible etiology for the embryonic lethality.
373M. Maitra et al. / Developmental Biology 326 (2009) 368–377On histologic examination, the E15.5 Gata4+/− Tbx5+/− embryos also
displayed a thin myocardium that appeared to affect the right and left
ventricle. (Fig. 3D and Supplementary movie). Examination of the
compound mutants at E11.5 showed no obvious myocardial hypoplasia
(data not shown) but thinningwas observed by E13.5.We quantiﬁed the
myocardial wall thickness in wild type, Gata4+/−, Tbx5+/−, and Gata4+/−
Tbx5+/− heterozygote E15.5 hearts and the Gata4+/− Tbx5+/− embryos had
signiﬁcantly thinner ventricular walls as compared to wildtype and
single heterozygote littermates (Fig. 3F). Our data suggests that the
mutant embryos were possibly dying after E15.5 from heart failure
secondary to the abnormal ventricular myocardium.Fig. 5. Cardiomyocyte defects in Cardiomyocyte defects in Gata4+/− Tbx5+/− embryos. (A)
staining is quantiﬁed in Gata4+/− Tbx5+/− embryonic hearts when compared to wildtype, G
E11.5. ⁎, p valueb0.05. (B) Real-time qRT-PCR demonstrates no signiﬁcant changes in Gat
Tbx5 mRNA levels are decreased by approximately 50% as predicted by heterozygosity of G
embryonic ventricles by real-time qRT-PCR while expression is unchanged in the Gata4+/− a
heterozygote or Tbx5+/− heterozygote littermates.In order to determine the etiology of the thin ventricular
myocardium in Gata4+/− Tbx5+/− embryos, we examined mutants at
earlier embryonic timepoints for defects in cardiomyocyte prolifera-
tion and apoptosis. In the Gata4+/− Tbx5+/− embryos, we did not
identify any changes in apoptosis in the ventricular myocardium at
E10.5, 11.5 and E13.5 (data not shown). We did observe decreased
cellular proliferation by phosphohistone H3 staining at E10.5 and
E11.5 in the compound heterozygotes that was more severe than the
single heterozygotes (Fig. 5A). These data suggest that the dosage of
Gata4 and Tbx5 is critical for normal cardiomyocyte proliferation
during the middle stages of cardiac development.Decreased cardiomyocyte proliferation as determined by phosphohistone H3 (PH3)
ata4+/− single heterozygote and Tbx5+/− single heterozygote littermates at E10.5 and
a6, Nkx2.5, Hey1, Hey2 and Myh7 expression in the embryonic ventricles. Gata4 and
ata4 and Tbx5. (C) Decreased expression of Myh6 mRNA is found in E13.5 and E11.5
nd Tbx5+/− single heterozygotes. ⁎, p valueb0.05 when compared to wildtype, Gata4+/−
Fig. 6. Neonatal lethality and no intrauterine growth retardation in Gata6+/− Tbx5+/−
embryos. (A) Frequency of genotypes obtained from intercrossing Gata6+/− mice with
Tbx5+/−mice. Neonatal lethality of Gata6+/− Tbx5+/− mice is demonstrated. (B) No growth
retardation of Gata6+/− Tbx5+/− embryos is seen at postnatal day 1. Scale bar represents
5 mm.
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Tbx5+/− mice, we performed real time qRT-PCR using RNA harvested
from ventricles of E13.5 embryos. We found the expression levels of
the cardiac transcription factors, Gata6, Nkx2.5, Hey1, and Hey2 in
E13.5 mutant ventricles were unchanged when compared to wildtype
ventricles (Fig. 5B). As expected, Gata4 and Tbx5 were downregulated
to ∼50% of wildtype levels. We did identify downregulation of Myh6
(α-myosin heavy chain) but not Myh7 (β-myosin heavy chain) in
these ventricles (Figs. 5B and C). Real-time qRT-PCR demonstrated
that Myh6 mRNA was expressed at lower levels in the compound
heterozygotes when compared to Gata4 and Tbx5 single heterozygotes
and was also decreased at an earlier timepoint (E11.5) (Fig. 5C).
Radioactive section in situ hybridization suggested that the down-
regulation was more pronounced in the ventricular myocardium, but
downregulation of Myh6 was also seen by semi-quantitative RT-PCR
when mRNA from whole hearts was analyzed (Supplementary Fig. 1).
Interaction of Gata6 and Tbx5
Gata6 has been shown to be important for cardiovascular
development and has been postulated to be functionally redundant
with Gata4. Similar to Gata4, Gata6 was co-expressed with Tbx5 in
the developing heart (Fig. 1) and was able to synergistically activate
an ANF-luciferase reporter in transactivation assays (Supplementary
Fig. 2). To determine if Gata6 exhibited a similar in vivo genetic
interaction with Tbx5 as Gata4, we generated Gata6+/− Tbx5+/− mice.
The Gata6+/− Tbx5+/− mice displayed an early neonatal lethality but
exhibited no growth retardation at E18.5 and post-natal day 1 (Fig. 6
and data not shown). Histologic analysis at E15.5 demonstrated
normal cardiac septation but myocardial thinning that predomi-
nantly involved the left ventricle was found in a subset of
compound mutants (Figs. 7A–C). The etiology for the nearly 100%
lethality is unclear and maybe due to a role for Gata6 and Tbx5 in
the conduction system or to abnormal contractile properties of the
myocardium (Davis et al., 2001; Zhu et al., 2008). No signiﬁcant
amount of apoptosis was found in the myocardium of E13.5 mutant
embryos when compared to wildtype littermates (data not shown),
but a deﬁcit in myocardial proliferation was demonstrated at E13.5
in these Gata6/Tbx5 compound heterozygotes (Fig. 7D). Interestingly,
the myocardial defect was less severe as compared to the Gata4+/−
Tbx5+/− embryos highlighting the unique and functional importance
of Gata4 at these stages. By real time qRT-PCR, there was normal
expression of several cardiac transcription factors except for the
expected downregulation of Gata6 and Tbx5. Interestingly unlike
the Gata4+/− Tbx5+/− embryos, there was also normal expression of
α-myosin heavy chain in Gata6+/−Tbx5+/− double heterozygote hearts
(Fig. 7E).
Discussion
The transcription factors, Gata4, Gata6 and Tbx5, are known to play
essential roles in cardiac development. Here, we have demonstrated
that combined haploinsufﬁciency of Gata4 and Tbx5 results in early
neonatal lethality and cardiovascular defects that are not seen in mice
heterozygous for null mutations of either gene. Furthermore, these
studies suggest that Gata4 and Tbx5 function in a cooperative manner
during formation of the atrioventricular septum andmaturation of the
myocardium. In addition, we describe a genetic interaction between
Gata6 and Tbx5. The cardiac phenotype in the Gata6+/− Tbx5+/−
double heterozygotes is less severe than the Gata4+/− Tbx5+/− double
heterozygotes suggesting unique in vivo roles for Gata4 and Gata6. In
addition, we identiﬁed that a common transcriptional target of Gata4
and Tbx5, Myh6, is speciﬁcally downregulated in Gata4+/− Tbx5+/−
embryos. These ﬁndings highlight the dosage sensitivity of cardiac
morphogenesis for appropriate levels of these critical transcription
factors.Cooperative functions of Gata4, Gata6 and Tbx5 during myocardial
development
Cardiac development is regulated by a highly conserved group of
cardiac transcription factors (Olson, 2006). Two of these, Gata4 and
Tbx5, have been well studied and play critical roles in the early stages
of cardiac morphogenesis. We previously reported the discovery of a
novel biochemical interaction between Gata4 and Tbx5 and demon-
strated their ability to cooperatively activate common luciferase
reporters in an in vitro system. Here we extended these ﬁndings to
show that Myh6, a proposed in vitro target of Gata4 and Tbx5, was
downregulated in the hearts of Gata4+/− Tbx5+/− embryos. Myh6 is
critical for normal cardiac development and Myh6-null mice die
between E11.0 and E12.0 of severe heart defects (Jones et al., 1996). In
vitro studies demonstrated that the cooperative activation of common
downstream targets required the independent binding of both Gata4
and Tbx5 (Garg et al., 2003). Our in vivo studies demonstrate that
haploinsufﬁciency of Gata4 and Tbx5 results in altered gene expres-
sion of a common downstream target, but it is not clear if this is the
result of decreased physical interaction Gata4 and Tbx5 or simply a
dosage effect in activation of target genes by Gata4 and Tbx5.
Our work demonstrates the importance of transcription factor
interactions in cardiac morphogenesis as we show that Gata4 and
Gata6 can genetically interact with Tbx5. Interestingly, haploinsufﬁ-
ciency of both Gata4 and Tbx5 led to defects in two cardiac
morphogenetic processes, atrioventricular septum formation and
myocardial development, while haploinsufﬁciency of Gata6 and Tbx5
resulted in only mild defects in myocardial development. Similar to
Tbx5, Gata4 is known to play an important role in myocardial
development as multiple mouse models of Gata4 deﬁciency result in
myocardial hypoplasia (Crispino et al., 2001; Zeisberg et al., 2005; Watt
et al., 2004; Pu et al., 2004) In addition, Gata6 has been shown to be
critical for cardiac differentiation and cardiomyocyte proliferation in
vivo such that haploinsufﬁciency of both genes causes lethality at E13.5
(Xin et al., 2006; Zhao et al., 2008). Our studies support a combination of
unique and redundant roles for Gata4 and Gata6 in myocardial
development. It is likely other cardiac transcription factors such as
Fig. 7. Cardiac defects inGata6+/− Tbx5+/− embryos. (A)Variablemyocardial thinning (arrowhead) is seen in a subset ofGata6+/− Tbx5+/−E15.5 embryos in coronal sectionof heartswhen compared
towildtype.Atrial septaldefect (asterisk) is found inaportionofdoubleheterozygotes. Scalebar represents100 μm;ra, right atrium; la, left atrium; ivs, interventricular septum; rv, rightventricle;
lv, left ventricle. (B) Table representing the frequency of cardiac abnormalities identiﬁed in each genotype at E15.5. ASD, atrial septal defect; VSD, ventricular septal defect; and AVSD,
atrioventricular septal defect. (C) Decreased thickness of compactmyocardium inGata6+/− Tbx5+/− double heterozygotes at E15.5 compared towild type,Gata6+/− single heterozygote andTbx5+/−
singleheterozygote littermates.Mean thickness asmeasured inmicrons is shown forbothventricles, left ventricle, and right ventricle. ⁎,pvalueb0.05. (D)Decreased cardiomyocyteproliferation
as determined byphosphohistoneH3 (PH3) staining is quantiﬁed inGata6+/− Tbx5+/− embryonic heartswhen compared towildtype,Gata6+/− andTbx5+/− single heterozygote littermates at E13.5.
⁎, p valueb0.05. (E) Real-time qRT-PCR demonstrates no signiﬁcant change in expression levels of Gata4, Nkx2.5, Hey1, Hey2, Myh7 andMyh6 in E13.5Gata6+/− Tbx5+/− embryonic hearts when
compared to wildtype littermates. Gata6 and Tbx5 mRNA levels are decreased by approximately 50% as predicted by heterozygosity of Gata6 and Tbx5. ⁎, p valueb0.05.
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376 M. Maitra et al. / Developmental Biology 326 (2009) 368–377Nkx2.5, which has been shown to interact with Gata4 and Tbx5, may
also play a role in regulating these later developmental processes. Of
note, we have not found an increased lethality in mice that are
heterozygous for all three transcription factors (unpublished data, V.G.).
Atrioventricular septation defects in Gata4+/− Tbx5+/− mice
The cardiovascular defects identiﬁed in mice heterozygous for
Gata4 and Tbx5 were limited to atrioventricular septation and
cardiomyocyte development. An atrioventricular septal defect has
traditionally been proposed to be the result of abnormal endocardial
cushion development. The process of endocardial cushion formation is
complex and starts at E9.5 in the mouse. At that stage, epithelial–
mesenchymal transformation (EMT) is critical for formation of the
endocardial cushion cells. In the Gata4/Tbx5 compound heterozygotes,
this initial process appears normal. This phenotype is similar to what
has been reported in several mouse models of atrioventricular septal
defect including myocardial-deletion of Bmp4; deletion of the Bmp
type I receptor, Alk3, in the cardiomyocytes of the atrioventricular
canal; and combined deﬁciency of Connexin 40 or 43 (Jiao et al., 2003;
Gaussin et al., 2002; Kirchhoff et al., 2000). In these mice, a normal
mesenchymal mass of endocardial cushion cells develops by E10.5 but
later remodeling does not occur resulting in an atrioventricular
septation defect. It has been proposed that this is due to continued
requirements of reciprocal signaling between the endocardium and
myocardium for these later stages of endocardial cushion remodeling.
In our Gata4/Tbx5 double heterozygote embryos, it is likely that a
similar phenomenon occurs. Gata4 and Tbx5 are co-expressed in
multiple cardiac cell lineages during cardiac morphogenesis, and
further studies are needed to identify the cell lineage that requires the
interaction of Gata4 and Tbx5 to result in this unique phenotype.
Ultimately, the elucidation of common downstream target genes in
these cells will be critical for understanding the mechanistic basis for
the atrioventricular septal defects in these mice.
GATA4, GATA6 and TBX5 in human congenital heart disease
Heterozygous mutations in GATA4 and TBX5 have been linked to
congenital heart defects in humans and likely result in haploinsufﬁ-
ciency leading to cardiac malformations (Garg et al., 2003; Basson et al.,
1997; Li et al., 1997). The CHD associated with mutations of GATA4 and
TBX5 are predominantly ostium secundum type atrial septal defects
although atrioventricular septal defects have been reported in children
with eitherGATA4mutations or Holt–Oramsyndrome (Garg et al., 2003;
Pierpont et al., 2000). From an embryologic standpoint, there is no clear
link between ostium secundumatrial septal defects and atrioventricular
septal defects as they are thought to have different cellular bases. Our
ﬁndings provide a plausible explanation for these clinical observations
since it is possible that childrenwith atrioventricular septal defectswho
have mutations in either GATA4 or TBX5 may harbor additional
mutations in other cardiac developmental genes.
To date, no mutations in GATA6 have been reported in children
with CHD but our data, along with recent publications, suggest that
GATA6 plays an important role in cardiac morphogenesis and is an
excellent candidate gene for causing CHD (Xin et al., 2006; Lepore et
al., 2006). In addition, our studies suggest that downstream targets of
GATA4 and TBX5 such as MYH6, which has already been implicated as
a cause of human atrial septal defects, are candidate genes for CHD
(Ching et al., 2005). Future studies that elucidate the molecular
pathways regulated by these transcription factors will lead to an
increased knowledge of the genetic basis of CHD.
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